title: Licensed to kill superbugs. Will a new class of antibiotic cut the incidence of hospital-acquired infections?
authors.forename: A
authors.initials: A
authors.lastname: O'Dowd
mesh_terms: D000081:Acetamides / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D003428:Cross Infection / Q000188:drug therapy*; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D006801:Humans; D000069349:Linezolid; D023303:Oxazolidinones / Q000627:therapeutic use*; D015163:Superinfection / Q000188:drug therapy*; D006113:United Kingdom
chemical_list: D000081:Acetamides; D000890:Anti-Infective Agents; D023303:Oxazolidinones; D000069349:Linezolid